|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 11,101,456.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2023) |
Target Yr (2024) |
Target Yr (2025) |
|---|---|---|---|---|
Anti-Retroviral Therapy (ART) Supplies |
No. of patients receiving ART (Millions) |
1.3 |
- |
- |
Artemisinin-Based Combination Therapy (ACT) Supplies |
No. of People receiving ACT (Millions) |
4.8 |
- |
- |
Tuberculosis (TB) Supplies |
% of TB patients treated and tested for HIV |
100 |
- |
- |
Anti-Retroviral Therapy (ART) Supplies
No. of patients receiving ART (Millions)
2023
1.3
2024
-
2025
-
Artemisinin-Based Combination Therapy (ACT) Supplies
No. of People receiving ACT (Millions)
2023
4.8
2024
-
2025
-
Tuberculosis (TB) Supplies
% of TB patients treated and tested for HIV
2023
100
2024
-
2025
-
Previous Year Allocations
Num |
Year |
Total |
|---|---|---|
1 |
KES 23,922,425.00 |
|
2 |
KES 22,520,960.00 |
|
3 |
KES 11,101,456.00 |
|
4 |
KES 6,099,626.00 |
|
5 |
KES 6,269,135.00 |
User Uploads
Funds disbursed to MDAs as a percentage of the external resources mobilized: 100
KES 240,262,679.00
(2023)
No. of feasibility studies conducted: 2
KES 61,000,000.00
(2023)
Budget transparency affects everyone — from roads to healthcare and education.
Help more Kenyans access this information by sharing or supporting this project.
☕ Buy Me a Coffee
This is a passion project that is built during late nights and weekends. Your support helps expand this platform — especially into county budgets.
: +254 707 903 301
: knjiru @ gmail.com